Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: Jefferson Research

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bio-Reference Laboratories Inc Issues FY 2013 Net Income Guidance; Revenue Guidance Above Analysts' Estimates

Monday, 25 Feb 2013 04:30pm EST 

Bio-Reference Laboratories Inc announced that for fiscal 2013, it expects net revenues to increase by greater than 15% and that we will grow net income by around 20%. The Company reported revenue of $661.6 million and net income of $42.16 million in fiscal 2012. According to I/B/E/S estimates, analysts were expecting the Company to report revenue of $748.0 million and net income of $49.5 million for fiscal 2013. 

Company Quote

-0.44 -1.45%
19 Dec 2014